Bussiness6 hours ago
NeuroSense Provides Business Update and Third Quarter 2024 Financial Results
CAMBRIDGE, Mass., Dec. 18, 2024 /PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today provided...
